An Institutional Biosafety Committee (IBC) Education Program was presented on Tuesday, September 27, 2005 at Weill Medical College of Cornell in Uris Auditorium by The National Institutes of Health (NIH) – Office of Biotechnology Activities (OBA)
Allan C. Shipp, M.H.A., Director of Outreach
Kathryn L. Harris, PhD, Senior Outreach & Education Specialist

The half-day seminar and lunch was hosted by the Research Integrity Division of the Office of Research and Sponsored Programs With support from Erik Talley, Director, Environmental Health and Safety and was open to the public and teleconferenced to The Methodist Hospital in Houston

The following are the PowerPoint presentations given by the OBA speakers:

1. Introduction to NIH OBA and the History of Recombinant DNA Oversight
2. Overview of the Current NIH Guidelines for Research Involving Recombinant DNA Molecules
3. Requirements for IBCs in the NIH Guidelines
4. Role of the Recombinant DNA Advisory Committee and the Protocol Review Process
5. Enhancing National Oversight of Dual Use Life Sciences Research

The WMC IBC homepage (Intranet only) may be reached at: intranet.med.cornell.edu/research/ibc.html